Neogen (NEOG) EBITDA Margin (2010 - 2026)
Neogen (NEOG) recorded EBITDA Margin of 14.43% in fiscal Q4 2026 (quarter ended May 31, 2026), up 272.03 percentage points from -257.61% a year earlier and up 2.30 percentage points from the prior quarter.
Neogen (NEOG) EBITDA Margin (2010 - 2026) Analysis & Trends
For FY2026 (ended May 31, 2026), Neogen reported EBITDA Margin of 10.88%, up 116.11 percentage points from FY2025.
- Annual EBITDA Margin has a five-year change of -9.44 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, EBITDA Margin came in at -105.23% in FY2025 (-124.20 pp), 18.97% in FY2024 (+3.66 pp), 15.31% in FY2023 (-0.31 pp) and 15.61% in FY2022 (-4.71 pp).
- The fiscal Q4 2026 figure is the highest quarterly EBITDA Margin since fiscal Q3 2025.
- On a year-over-year basis, EBITDA Margin rose in two of the last eight quarters, with an average year-over-year change of -4.09 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 272.03 percentage points in fiscal Q4 2026, against a drop of 275.27 percentage points in fiscal Q4 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at 12.13% (Q3 2026), 10.48% (Q2 2026) and 6.20% (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Neogen | 2.79 Bn | 2.16 Bn | 107.80 Mn | 14.43% |
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 14.43% |
| Feb 28, 2026 | 12.13% |
| Nov 30, 2025 | 10.48% |
| Aug 31, 2025 | 6.20% |
| May 31, 2025 | -257.61% |
| Feb 28, 2025 | 15.72% |
| Nov 30, 2024 | -184.83% |
| Aug 31, 2024 | 14.78% |
| May 31, 2024 | 17.66% |
| Feb 29, 2024 | 18.21% |
| Nov 30, 2023 | 19.13% |
| Aug 31, 2023 | 20.90% |
| May 31, 2023 | 21.45% |
| Feb 28, 2023 | 19.77% |
| Nov 30, 2022 | 8.30% |
| Aug 31, 2022 | 8.91% |
| May 31, 2022 | 17.05% |
| Feb 28, 2022 | 9.90% |
| Nov 30, 2021 | 14.02% |
| Aug 31, 2021 | 21.38% |
Neogen EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEOG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NEOG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NEOG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();